Asset Details
Do you wish to reserve the book?
Varicella paediatric hospitalisations in Belgium: a 1-year national survey
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Varicella paediatric hospitalisations in Belgium: a 1-year national survey
Do you wish to request the book?
Varicella paediatric hospitalisations in Belgium: a 1-year national survey
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Varicella paediatric hospitalisations in Belgium: a 1-year national survey
2016
Overview
Varicella universal vaccination (UV) has been implemented in many countries for several years. Nevertheless, varicella UV remains debated in Europe and few data are available on the real burden of infection. We assessed the burden of varicella in Belgium through analysis of hospitalised cases during a 1-year period.
Data on children admitted to hospital with varicella were collected through a national network from November 2011 to October 2012. Inclusion criteria were either acute varicella or related complications up to 3 weeks after the rash.
Participation of 101 hospitals was obtained, covering 97.7% of the total paediatric beds in Belgium. 552 children were included with a median age of 2.1 years. Incidence of paediatric varicella hospitalisations reached 29.5/10(5) person-years, with the highest impact among those 0-4 years old (global incidence and odds of hospitalisation: 79/10(5) person-years and 1.6/100 varicella cases, respectively). Only 14% (79/552) of the cohort had an underlying chronic condition. 65% (357/552) of children had ≥1 complication justifying their admission, 49% were bacterial superinfections and 10% neurological disorders. Only a quarter of children (141/552) received acyclovir. Incidence of complicated hospitalised cases was 19/10(5) person-years. Paediatric intensive care unit admission and surgery were required in 4% and 3% of hospitalised cases, respectively. Mortality among Belgian paediatric population was 0.5/10(6) and fatality ratio 0.2% among our cohort.
Varicella demonstrated a substantial burden of disease in Belgian children, especially among the youngest. Our thorough nationwide study, run in a country without varicella UV, offers data to support varicella UV in Belgium.
Publisher
BMJ Publishing Group Ltd,BMJ Publishing Group
Subject
/ Analysis
/ Antiviral Agents - therapeutic use
/ Chickenpox - prevention & control
/ Child
/ Children
/ Drug Utilization - statistics & numerical data
/ Europe
/ Female
/ Hospitalization - statistics & numerical data
/ Humans
/ Immunologie & maladie infectieuse
/ Immunology & infectious disease
/ Infant
/ Male
/ Original
/ Sciences de la santé humaine
